Novo Nordisk CEO's ouster signals stiff competition in the obesity market, getting dominated by Eli Lilly, with Roche, ...

The latecomer PD-1 inhibitor – already approved for Merkel cell carcinoma – has become the first cancer immunotherapy for ...

India], May 16: Merck Foundation, the philanthropic arm of Merck KGaA Germany, marks ‘World Hypertension Day 2025’ in ...

Merck Foundation partners with African First Ladies and others to tackle diabetes and hypertension through education and ...

Bayer BAYRY announced first-quarter 2025 results. Novo Nordisk NVO and GSK plc GSK announced licensing deals with smaller ...

Researchers analyzed long-term survival of women diagnosed with low-risk cervical cancer, from 2010 through 2017, who ...

MSD has reported that the Phase III KEYNOTE-B96 trial of Keytruda plus paclitaxel, with or without bevacizumab, has met its ...

Rahway, New Jersey Friday, May 16, 2025, 13:00 Hrs [IST] ...